Fund Holdings — RTW INVESTMENTS, LP

Total Portfolio Value:
$6.77B
Total Bought:
$1.66B
Total Sold:
$1.16B
Net Transaction:
+$505.18M
Notable People:
Roderick Tze Ian Wong, Rtw Investments Gp, Llc, Peter M Fong
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Rocket Pharmaceuticals, Inc.(RCKT)17,687,77217,687,7720$530.10M$476.51M7.03%-$53.59M
Immunocore Holdings plcADS(IMCR)6,096,3876,019,641-76,746$416.51M$391.28M5.78%-$25.23M
Axsome Therapeutics, Inc.(AXSM)4,489,5964,492,679+3,083$357.33M$358.52M5.29%+$1.19M
Ultragenyx Pharmaceutical Inc.(RARE)6,887,0867,087,115+200,029$329.34M$330.90M4.88%+$1.56M
Bruker Corporation(BRKR)3,344,0953,344,0950$245.72M$314.14M4.64%+$68.42M
argenx SEADR(ARGX)667,195667,1950$253.82M$262.69M3.88%+$8.87M
Acadia Pharmaceuticals Inc11,253,55113,829,315+2,575,764$352.35M$255.70M3.77%-$96.64M
Natera, Inc.(NTRA)2,593,3232,593,3230$162.45M$237.19M3.50%+$74.74M
PTC Therapeutics, Inc.(PTCT)7,423,9707,423,9700$204.60M$215.96M3.19%+$11.36M
Masimo Corp1,462,4001,462,4000$171.41M$214.75M3.17%+$43.35M
Avidity Biosciences Inc6,689,7897,970,269+1,280,480$60.54M$203.40M3.00%+$142.86M
Merus N V2,373,6254,109,393+1,735,768$65.27M$185.05M2.73%+$119.77M
Cytokinetics, Incorporated(CYTK)2,525,0802,525,0800$210.82M$177.03M2.61%-$33.79M
Apogee Therapeutics Inc2,142,5912,467,591+325,000$59.86M$163.97M2.42%+$104.11M
Alkermes plcSHS(ALKS)3,901,5236,054,280+2,152,757$108.23M$163.89M2.42%+$55.66M
Protagonist Therapeutics Inc5,315,5145,315,5140$121.88M$153.78M2.27%+$31.89M
Penumbra, Inc.(PEN)662,664675,888+13,224$166.69M$150.84M2.23%-$15.84M
Avadel Pharmaceuticals PlcADR6,947,9188,798,558+1,850,640$98.10M$148.61M2.19%+$50.50M
Akero Therapeutics Inc3,592,7595,431,985+1,839,226$83.89M$137.21M2.03%+$53.32M
Establishment Labs Holdings Inc.(ESTA)2,494,1382,675,703+181,565$64.57M$136.19M2.01%+$71.62M
Arvinas, Inc.(ARVN)4,213,4833,297,897-915,586$173.43M$136.14M2.01%-$37.29M
Tarsus Pharmaceuticals, Inc.(TARS)3,152,3413,272,341+120,000$63.83M$118.95M1.76%+$55.11M
Stryker Corporation(SYK)0321,000+321,000$0$114.88M1.70%+$114.88M
Madrigal Pharmaceuticals, Inc.(MDGL)815,191397,047-418,144$188.62M$106.03M1.57%-$82.59M
Immatics N.V.SHS(IMTX)1,484,91110,000,000+8,515,089$15.64M$105.10M1.55%+$89.46M
Sage Therapeutics Inc5,197,0195,480,577+283,558$112.62M$102.71M1.52%-$9.91M
Shockwave Med Inc65,060288,684+223,624$12.40M$94.00M1.39%+$81.61M
Dyne Therapeutics, Inc.(DYN)03,091,587+3,091,587$0$87.77M1.30%+$87.77M
89bio Inc5,578,9317,378,548+1,799,617$62.32M$85.89M1.27%+$23.57M
Spyre Therapeutics, Inc.(SYRE)2,232,7602,232,7600$48.05M$84.69M1.25%+$36.64M
Vericel Corporation(VCEL)3,212,7941,606,397-1,606,397$114.41M$83.56M1.23%-$30.84M
Cargo Therapeutics Inc5,175,8323,735,619-1,440,213$119.82M$83.38M1.23%-$36.44M
RadNet, Inc.(RDNT)663,6021,700,550+1,036,948$23.07M$82.75M1.22%+$59.68M
Thermo Fisher Scientific Inc.(TMO)50,000110,500+60,500$26.54M$64.22M0.95%+$37.68M
10x Genomics, Inc.CL A(TXG)1,549,9511,554,856+4,905$86.74M$58.35M0.86%-$28.38M
Stoke Therapeutics, Inc.(STOK)4,131,0454,224,838+93,793$21.73M$57.04M0.84%+$35.31M
Fulcrum Therapeutics, Inc.(FULC)5,469,9565,845,956+376,000$36.92M$55.19M0.81%+$18.26M
Taysha Gene Therapies, Inc.(TSHA)16,893,18518,593,185+1,700,000$29.90M$53.36M0.79%+$23.46M
Insmed Incorporated(INSM)1,865,1081,865,1080$57.80M$50.60M0.75%-$7.20M
UroGen Pharma Ltd.(URGN)1,726,8083,257,347+1,530,539$25.90M$48.86M0.72%+$22.96M
Kyverna Therapeutics, Inc.(KYTX)01,852,711+1,852,711$0$46.02M0.68%+$46.02M
Intuitive Surgical, Inc.(ISRG)099,000+99,000$0$39.51M0.58%+$39.51M
Neurogene Inc.(NGNE)0769,122+769,122$0$39.15M0.58%+$39.15M
Janux Therapeutics, Inc.(JANX)01,000,000+1,000,000$0$37.65M0.56%+$37.65M
GH Research PLC(GHRS)3,327,1293,327,1290$19.30M$35.47M0.52%+$16.17M
Orchestra BioMed Holdings, Inc.(OBIO)5,620,6405,620,6400$51.32M$29.62M0.44%-$21.70M
Dianthus Therapeutics, Inc.(DNTH)0666,667+666,667$0$20.00M0.30%+$20.00M
Essa Pharma Inc2,298,6622,298,6620$15.17M$19.52M0.29%+$4.34M
LENZ Therapeutics, Inc.(LENZ)0863,389+863,389$0$19.28M0.28%+$19.28M
CG Oncology, Inc.(CGON)0413,670+413,670$0$18.16M0.27%+$18.16M
Tourmaline Bio Inc398,850741,656+342,806$10.44M$16.98M0.25%+$6.54M
Roivant Sciences Ltd.SHS(ROIV)1,454,2731,454,2730$16.33M$15.33M0.23%-$1.00M
Viridian Therapeutics, Inc.(VRDN)605,816605,8160$13.19M$10.61M0.16%-$2.59M
Adicet Bio Inc4,134,6314,134,6310$7.81M$9.72M0.14%+$1.90M
REGENXBIO Inc.(RGNX)0350,000+350,000$0$7.37M0.11%+$7.37M
Acelyrin Inc978,310978,3100$7.30M$6.60M0.10%-$694.6K
Endeavour Silver Corp.(EXK)095,000+95,000$0$6.56M0.10%+$6.56M
Allurion Technologies Inc3,457,7073,457,7070$12.93M$6.05M0.09%-$6.88M
Immunic, Inc.(IMUX)4,335,2554,567,717+232,462$6.50M$6.03M0.09%-$473.5K
Milestone Pharmaceuticals Inc.(MIST)3,256,1023,256,1020$5.44M$5.83M0.09%+$390.7K
Glaukos Corporation(GKOS)058,791+58,791$0$5.54M0.08%+$5.54M
Sagimet Biosciences Inc.COM SER A(SGMT)0999,147+999,147$0$5.42M0.08%+$5.42M
Larimar Therapeutics, Inc.(LRMR)0650,000+650,000$0$4.93M0.07%+$4.93M
SAB Biotherapeutics, Inc.(SABS)0917,827+917,827$0$4.17M0.06%+$4.17M
Exagen Inc.(XGN)1,504,6021,504,6020$2.99M$2.39M0.04%-$601.8K
Beyond Air, Inc.(XAIR)01,204,820+1,204,820$0$2.10M0.03%+$2.10M
Cutera Inc1,817,5851,331,776-485,809$6.41M$1.96M0.03%-$4.45M
Arya Sciences Acqu Corp IvCL A127,970127,9700$1.39M$1.44M0.02%+$42.2K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)350,000350,0000$171.5K$104.7K0.00%-$66.8K
Alnylam Pharmaceuticals, Inc.(ALNY)1,640,5590-1,640,559$314.02M$0—-$314.02M
Apyx Medical Corporation(APYX)1,025,9630-1,025,963$2.69M$0—-$2.69M
Celldex Therapeutics, Inc.(CLDX)3,463,2010-3,463,201$137.35M$0—-$137.35M
Danaher Corporation(DHR)118,5840-118,584$27.43M$0—-$27.43M
Guardant Health, Inc.(GH)492,9770-492,977$13.34M$0—-$13.34M
Mirati Therapeutics Inc6,768,5140-6,768,514$397.65M$0—-$397.65M
SAB Biotherapeutics, Inc.(SABS)9,178,2820-9,178,282$6.31M$0—-$6.31M
Sientra Inc81,0160-81,016$49.4K$0—-$49.4K
Sight Sciences, Inc.(SGHT)164,8060-164,806$850.4K$0—-$850.4K
Springworks Therapeutics Inc625,0000-625,000$22.81M$0—-$22.81M
Tango Therapeutics, Inc.(TNGX)1,966,7520-1,966,752$19.47M$0—-$19.47M
Page 1 of 1
RTW INVESTMENTS, LP — 13F Holdings — Q1 2024 | TickerTrail